M&A Deal Summary

Johnson & Johnson Acquires Pfizer Consumer Healthcare

On June 26, 2006, Johnson & Johnson acquired life science company Pfizer Consumer Healthcare from Pfizer for 16.6B USD

Acquisition Highlights
  • This is Johnson & Johnson’s 4th transaction in the Life Science sector.
  • This is Johnson & Johnson’s 4th largest (disclosed) transaction.
  • This is Johnson & Johnson’s 1st transaction in Germany.

M&A Deal Summary

Date 2006-06-26
Target Pfizer Consumer Healthcare
Sector Life Science
Buyer(s) Johnson & Johnson
Sellers(s) Pfizer
Deal Type Divestiture
Deal Value 16.6B USD

Target

Pfizer Consumer Healthcare

Berlin, Germany
Pfizer Consumer Healthcare GmbH global business of personal care and over-the-counter (OTC) products. A leading brands include LISTERINE oral care products and the NICORETTE line of smoking cessation treatments. Other widely recognized and trusted brands include LUBRIDERM, VISINE, NEOSPORIN, SUDAFED, ZANTAC and BENADRYL.

Search 199,968 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States

Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 85.2B USD (2023)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.


DEAL STATS #
Overall 16 of 45
Sector (Life Science) 4 of 18
Type (Divestiture) 3 of 4
Country (Germany) 1 of 1
Year (2006) 2 of 3
Size (of disclosed) 4 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-02 FMS Future Medical System S.A.

Geneva, Switzerland

FMS Future Medical System S.A. manufactures and markets arthroscopic fluid management systems.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-11-16 Conor Medsystems

Menlo Park, California, United States

Conor Medsystems, Inc.developed stents and other medical devices as platforms for controlled local and systemic delivery of a wide variety of therapeutic agents. The Company's initial focus was on drug-eluting stents for the treatment of restenosis and vascular disease.

Buy $1.4B

Seller(S) 1

SELLER

Pfizer

New York, New York, United States

Category Company
Founded 1849
Sector Life Science
Employees8,300
Revenue 58.5B USD (2023)
DESCRIPTION
Pfizer office in Lake Forest, Illinois.
Pfizer office in Lake Forest, Illinois.

Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.


DEAL STATS #
Overall 5 of 18
Sector (Life Science) 2 of 13
Type (Divestiture) 5 of 15
Country (Germany) 2 of 2
Year (2006) 1 of 1
Size (of disclosed) 1 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-04-06 Rinat Neuroscience

Palo Alto, California, United States

Rinat Neuroscience Corp. a biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-02-09 BioRexis Pharmaceuticals

King of Prussia, Pennsylvania, United States

BioRexis Pharmaceuticals Corp. is a bio-pharmaceutical company produces biopharmaceuticals.

Buy -